Skip to main content
Brain Communications logoLink to Brain Communications
. 2026 Aug 31;8(4):fcag301. doi: 10.1093/braincomms/fcag301

A vascular component to the selective vulnerability of the medial temporal lobe to tau pathology

Vincent Doyon 1, Félix Janelle 2,3, Monica Sean 4, Davy Vanderweyen 5, Samantha Côté 6, Julia Huck 7, Pascal Tétreault 8,9, Jean-François Lepage 10,11, Jose Gutierrez 12, Christian Bocti 13, Tamàs Fülöp 14, Alexa Pichet-Binette 15,16, Kevin Whittingstall 17,18,19,✉
PMCID: PMC13527872  PMID: 42677148

Abstract

The medial temporal lobe is widely recognized as an early site of pathological tau deposition, a central feature in the development of cognitive symptoms. As of now, the biological mechanisms underlying this selective vulnerability of the medial temporal lobe are not yet understood. Here, we tested whether alterations in medial temporal lobe arterial structure are associated with early tau accumulation and cognitive decline. We first applied a novel imaging methodology (super-selective arterial spin labelling) to map vascular supply to the medial temporal lobe. Next, we cross-sectionally investigated the relationship between medial temporal lobe artery diameters and tau burden, derived from magnetic resonance angiography and positron emission tomography imaging, in 151 cognitively unimpaired individuals (mean age: 67.6 years old). Finally, we examined whether artery diameter was correlated with the rate of cognitive decline in a separate cohort of 43 individuals (mean age: 74.2 years old). We found that the blood supply to the medial temporal lobe depended more on arteries from the anterior circulation than the posterior circulation. Individuals with small anterior choroidal artery diameters tended to show higher medial temporal lobe tau burden (r = −0.26, P = 0.001) and faster rates of cognitive decline (r = −0.40, P = 0.012). These results remained significant after adjusting for potential confounding factors such as amyloid burden. Our results show that anterior choroidal artery diameter may be an amyloid-independent determinant of tau pathology and cognitive decline. This suggests that the selective vulnerability of the medial temporal lobe may emerge from subpar perfusion from the anterior circulation.

Keywords: brain artery, vascular, circle of Willis, aging, Alzheimer’s disease


Doyon et al. found that individuals with narrower anterior choroidal arteries, which supply the anterior portion of the medial temporal lobe, have higher tau burden and experience faster cognitive decline.

Graphical Abstract

Graphical Abstract.

For graphical abstract description, please refer to the textual abstract.

Introduction

The medial temporal lobe (MTL) is a critical brain region encompassing structures that are essential for memory formation, long-term storage and spatial navigation.1,2 During normal aging, subregions of the MTL such as the hippocampus, the amygdala and the entorhinal cortex are among the first to undergo detrimental changes,3 most notably the accumulation of pathological tau proteins.4 In a physiological context, tau is involved in axonal transport and structural integrity; however, under pathological conditions, it becomes hyperphosphorylated and tends to aggregate and form neurofibrillary tangles, which are toxic to neurons.5 It has been shown that tau levels in the MTL of cognitively unimpaired (CU) individuals increase the risk of future cognitive decline,6-8 highlighting the importance of identifying the factors driving tau accumulation. Individuals with elevated amyloid beta (Aβ) tend to accumulate tau more rapidly than those without, suggesting that Aβ may act as a key driver of tau pathology and tau-mediated neurodegeneration.9,10 However, because Aβ and tau pathologies initially accumulate in different brain regions11 and tau aggregation can precede Aβ deposition,12,13 the idea that tau pathology is solely driven by Aβ pathology is controversial.14 Regional gene expression associated with tau pathology is thought to be the main cause behind the MTL’s ‘selective vulnerability’, but other mechanisms may also play a role.15

Maintaining adequate cerebral blood flow is essential for overall brain health, cognitive function and prevention of neurological disorders. In humans, oxygen-rich blood reaches the brain via the Circle of Willis, a ring-like arterial structure located at the base of the brain. Human autopsy and animal studies have shown that luminal narrowing of the Circle of Willis arteries is associated with increased tau burden,16-19 presumably due to chronic hypoperfusion.20-23 Moreover, in vivo human imaging studies show that the vascular architecture supplying blood to the MTL is an important determinant of cognitive health,24,25 thus raising the possibility that arterial structure supplying the MTL may be an important component of its selective vulnerability. The so-called ‘vascular’ theory of selective vulnerability was first proposed over a century ago,26 yet has since then been largely ignored and experimental data linking it to tau pathology and cognition remain limited.

To investigate this, we used a fully automated method to analyse the Circle of Willis arteries on magnetic resonance angiography (MRA) images. With this, we correlated their lumen diameters with (i) tau burden in the MTL, measured with PET in cognitively unimpaired individuals (CU, N = 151); and (ii) longitudinal measures of the rate of cognitive decline in a separate cohort of individuals with mild cognitive impairment (MCI, N = 43). As a complementary experiment, we sought to establish the perfusion territories of MTL arteries using super-selective arterial spin labelling (ss-ASL).

Materials and methods

Artery-specific supply of the MTL

We performed ss-ASL in five young participants (mean age = 27.2 ± 4.5 years old, two males and three females). Imaging protocol was approved by the review board of the Centre Hospitalier Universitaire de Sherbrooke, and all participants gave their written informed consent for this study. Each participant underwent a 40 min scan on a 3T Ingenia Phillips scanner equipped with a 32-channel head coil (Philips Healthcare, Best, Netherlands). The imaging session included a time-of-flight sequence centered on the pons (field of view (FOV) = 320 × 320 × 162, TR = 23 ms, TE = 3.454 ms, voxel size of 0.625 × 0.625 × 0.750 mm, total scan time = 3 minutes 52 seconds), two pseudo-continuous ss-ASL sequences for which the FOV was centered on the MTL and a high-resolution T1-weighted image of the whole brain (FOV = 224 × 224 × 160, TR = 7.9 ms, TE = 3.5 ms, voxel size of 1 × 1 × 1 mm, total scan time = 4 minutes 19 seconds).

For the ss-ASL sequences (FOV = 80 × 80 × 10, TR = 5100 ms, TE = 16.077 ms, voxel size of 3 × 3 × 5 mm, post-label delay = 1700ms, label duration = 1650 ms, number of pairs of control/label images: 60, scan time for a single tagging = 10 min 22 s), blood from the anterior circulation was labelled about 60 mm down the Circle of Willis in the cervical segment of the internal carotid artery (ICA). For the posterior circulation, labelling was performed ∼75 mm down the Circle of Willis in the V2 segment of the vertebral arteries (VA). To tag both vertebral arteries and thus increase the tagging efficiency, labelling selectivity was removed along the left-right axis by omitting a magnetic gradient as previously described in Murazaki et al. (2022).27 For one participant, two ss-ASL images of the vertebral arteries were obtained and summed during preprocessing due to a low signal-to-noise ratio in a single acquisition.

To ensure that tagged blood from the anterior circulation did not travel to the posterior cerebral artery (PCA) through the posterior communicating artery and thus contaminate the signal, only participants with hypoplastic posterior communicating arteries on their MRA images were included.

All MRI images were converted from DICOM to NIFTI format using dcm2niix (version v1.0.20220505). A combination of AFNI (version 24.3.00) and FSL tools (version 6.0.7.12) was used for the following steps. The ss-ASL images were first registered to the T1-weighted image. Brain segmentation was performed on the high-resolution T1-weighted images using FastSurfer.28 The hippocampus was delineated into three subregions (head, body and tail) using k-means clustering. While this method does not account for the anatomical boundaries of each hippocampal subregion, it effectively separates the hippocampus into three regions along its anterior–posterior axis.

To standardize ASL units, each voxel intensity was divided by the mean intensity value of a composite region typically perfused by the tagged artery. The composite regions included the grey matter of the superior and medial temporal cortex, supramarginal cortex, insula and putamen for the ICA. The composite region for the posterior circulation consisted of the grey matter of the precuneus and lingual cortex. Resulting ASL image units therefore represented the percentage of perfusion of the composite region. Clustering was then performed on ASL images to reduce noise level with the following parameters: threshold value = 0.4, minimal number of voxels to be considered a cluster = 20, face-wise connectivity.

To determine the supply dependency of each MTL region, a voxel with a value of 40% or over was assumed to be irrigated by the tagged artery. The 40% threshold represents the upper limit at which nearly all grey matter voxels were perfused by either the internal carotid artery or the basilar artery. The proportion of irrigation within each MTL region was calculated as the number of irrigated voxels divided by the total number of voxels in that region.

Relationship between tau and artery size

The correlation between tau levels and artery diameter was analysed using the OASIS dataset,29 which includes MRI and PET images from CU participants. MRI acquisitions were conducted using a Biograph mMR or a TrioTim scanner equipped with a 16-channel head coil. For PET scans, a Biograph mMR, Biograph 40 PET/CT or an ECAT HRplus 962 scanner was used. To measure tau levels, 370 MBq of Flortaucipir was used as a tracer and images were acquired 75 min post-injection for a duration of 30 min. Amyloid burden was assessed with AV45 (370 MBq) or PIB tracer (222 MBq to 740 MBq). Other relevant information regarding PET and MRI acquisition procedures is detailed at https://sites.wustl.edu/oasisbrains/home/oasis-3/.

Data from 151 CU participants were analysed (Table 1). We included participants with a clinical dementia rating (CDR) score of 0, and with MRA, tau-PET, amyloid-PET, sociodemographic and health-related information available. Arterial diameter size was extracted from MRA images using eiCAB (express IntraCranial Arteries Breakdown), a fully automated method for accurate artery identification and diameter measurement recently introduced by our group.30,31 The arteries of interest in this study were the PCA, the middle cerebral artery (MCA) and AChA as these are commonly reported as being the main arterial supply routes to the MTL32-34 (Fig. 1). Therefore, diameter measurements from eICAB were obtained for the M1 segment of the MCA, the P1 segment of the PCA and the cisternal segment of the AChA. As a proxy marker for blood flow,35 artery length was estimated by the total number of skeleton voxels for each artery mask. For tau–PET data, images were first registered to their corresponding T1-weighted image and subsequently registered in MNI space. PET data were normalized to standardized uptake value ratios (SUVRs) by dividing each voxel’s intensity by the mean intensity of the entire cerebellum, which served as a reference region. Mean SUVRs of the brain were extracted based on FreeSurfer version 5.3 segmentation. The MTL was defined as the composite region of the amygdala, entorhinal cortex and parahippocampal cortex. The hippocampus region was excluded from the tau analysis because of off-target binding of the tau tracer in the choroid plexus.36

Table 1.

Social and health-related information of CU individuals

Participants
N 151
Sex (% of male) 40%
Mean age (years) 67.6
Mean number of cardiovascular risk factors 1.8
Mean education (years) 16.2
Mean amyloid whole-brain (SUVr) 1.12

The cardiovascular risk factors were recorded as binary variables and included hypertension, diabetes, smoking, obesity and hypercholesterolaemia.

SUVr: relative standardized uptake value.

Figure 1.

This figure shows the location of the anterior choroidal artery and the posterior cerebral artery relative to the medial temporal lobe.

Medial temporal lobe arteries. (A) Axial TOF-MRI at the level of the AChA and the PCA. (B) 3D rendering of the main arteries of the CW segmented with eICAB adjacent to MTL regions. AChA: anterior choroidal artery. MCA: middle cerebral artery. PCA: posterior cerebral artery. TOF-MRA: time-of-flight magnetic resonance angiography. CW: circle of Willis. eICAB: express intracranial arteries breakdown. MTL: medial temporal lobe.

Relationship between cognitive decline and artery size

The dataset used for the cognitive decline analysis was also acquired from OASIS.37 Information about data acquisitions can be found at: https://sites.wustl.edu/oasisbrains/home/oasis-3/.

MRA images from all participants with a baseline CDR score of 0.5 and at least one longitudinal follow-up were processed using eICAB (n = 43). This analysis was only performed on individuals with MCI, as too few participants in the CU group underwent cognitive decline. To assess the rate of cognitive decline, we computed the slope of the CDR-sum of boxes (CDR-SB) score over time (Δ CDR-SB/year). We used CDR-SB instead of CDR because of its greater range of values and utility in accurately tracking changes in cognition.38,39 Participants with a CDR-SB pts./year value greater than zero were assumed to be declining (N = 23, +1.37 pts./year) while the remaining were assumed to be stable (N = 20, −0.45 pts./year). These numbers are consistent with large-scale studies showing that approximately half of MCI patients remain cognitively stable over an ∼2-year period.40,41 The two groups did not differ significantly in age, sex, cardiovascular disease and MR image quality (Table 2).

Table 2.

Social and health-related information of MCI individuals

Slow decline Fast decline P-value
N 20 23
Sex (% of male) 50% 43% 0.67
Mean age (years) 72.5 75.7 0.16
Follow-up (years) 1.74 2.26 0.11
Cardiovascular disease (%) 20 26 0.44
Mean education (years) 17.4 14.7 0.002
Amyloid whole-brain (SUVr) 1.34 1.67 0.007

The cardiovascular disease column represents the percentage of participants with at least one cardiovascular disease.

SUVr: relative standardized uptake value.

Statistical analyses

The mean of the left and right measurements for arterial diameter and tau load was used for statistical analysis. Spearman correlations were calculated to assess the relationship between arterial diameter and tau burden/cognitive decline. Correlation analyses were reported both with and without correcting for confounding factors. Previous studies have shown that age and amyloid burden are associated with artery size and tau burden,4,9,42 therefore potentially acting as confounding factors in our correlation analyses. Thus, age and amyloid load were included as covariates in the assessment of tau-artery size relationship. Similarly, because there is evidence that amyloid levels and education are associated with cognitive decline,43,44 correcting for these in the cognitive decline analysis was considered appropriate. Since we tested three arterial segments, we employed the Holm–Bonferroni method to correct for multiple comparisons, and the subregion analyses were reported as exploratory. In the cognitive decline study, five participants were excluded from the corrected analysis due to missing amyloid data. Student’s t-tests were used to compare arterial diameters between declining and stable MCI participants.

Results

Vascular supply to the MTL

Post-mortem studies33,45 indicate that the MTL is supplied by arteries forming in the anterior (MCA, AChA) and posterior circulation (PCA, Fig. 1), yet in vivo evidence of their respective contributions has been lacking. To address this, we scanned five young, healthy participants using an ss-ASL sequence (see Methods) to map the areas of the MTL supplied by anterior, posterior or both (mixed) circulations. We chose to scan young participants to ensure that our findings accurately reflected normal perfusion. Older adults might display age-related changes, such as stenosis, that could affect perfusion territories and bias the experiment. An example of an unprocessed ss-ASL image from one participant is shown in Fig. 2A. Group-averaged maps of vascular supply (see Methods) are shown in Fig. 2B-C. MTL regions such as the amygdala and hippocampal head region were almost exclusively perfused by the anterior circulation, whereas parahippocampal cortex and hippocampal tail regions were more primarily supplied by the posterior circulation (Fig. 2D-F). To our knowledge, these findings are the first in vivo observations revealing a distinct vascular supply gradient of the MTL, transitioning from anterior circulation supply to the amygdala and hippocampal head, to a posterior circulation supply to the hippocampal tail.

Figure 2.

This figure shows the perfusion gradient of the medial temporal lobe, transitioning from the anterior circulation in the antero-medial segment of the medial temporal lobe to the posterior circulation in its postero-lateral part.

Supply gradient of the MTL. (A) Example of an ss-ASL image when tagging arterial blood in the right ICA, which is directly beneath the AChA, and the VA. (B) A representative case of a perfusion map applied to a 3D surface reconstruction of the MTL showing the difference in n.v.i between ICA and VA. (C) Similar map as in B, but showing voxels meeting a threshold of 0.4 n.v.i for each arteries. (D) Corresponding regions of the MTL. (E) Mean normalized voxel intensity for each region on ICA-tagged and VA-tagged images (N = 5 participants). (F) Percentage of the region irrigated by the ICA and the VA based on a 0.4 n.v.i threshold. Each data point represents a participant. n.v.i: normalized voxel intensity. ICA: internal carotid artery. VA: vertebral arteries. A: anterior. P: posterior. MTL: medial temporal lobe.

MTL tau is higher in CUs with small AChAs

We next examined whether the calibre of the vessels feeding the MTL is associated with tau levels. To address this, tau–PET and MRA images were analysed in 151 CU individuals (Fig. 3A). On average, tau levels were significantly higher in the MTL compared to the frontal (P < 0.0001), parietal (P < 0.0001) and occipital cortices (P < 0.0001), consistent with the known selective vulnerability of the MTL to tau pathology in early stages (Fig. 3B). MTL tau burden correlated negatively with AChA diameter (r = −0.26, P = 0.001, Fig. 3C), but not with MCA or PCA diameter (P > 0.8). The association between AChA diameter and MTL tau remained significant after correcting for age, neocortical Aβ levels (r = −0.19, P = 0.02) and multiple comparison. Log-transforming the AChA diameter did not alter the association with tau levels. Within the MTL, AChA diameter showed the strongest correlation with tau levels in the amygdala and weakest with tau in the entorhinal cortex (Fig. 3D). We did not find any association between the length of any of our arteries of interest and tau levels in the MTL (all P > 0.3), suggesting a flow-independent relationship between AChA diameter and tau levels.

Figure 3.

This figure shows the negative correlation between the anterior choroidal artery diameter and tau burden in the medial temporal lobe.

AChA diameter is associated with MTL tau. (A) Lumen diameter of the CW arteries across a CU population (N = 151 participants). The error bar represents the standard deviation. (B) Distribution of tau burden for all subjects in major regions of the brain. One-way ANOVA with Tukey’s honestly significant difference test was used to assess differences between regions (F = 122.5, P < 0.0001). (C) Scatter plots of the association between AChA diameter and tau burden in the MTL. The 95% confidence intervals are represented in grey areas. (D) Raw correlation between AChA diameter and regional tau load. In sub-panels C and D, Spearman’s rank correlation was used to assess these relationships. In sub-panel A, B and C, each datapoint represents a participant and values are average of both hemispheres. ctx: cortex. SUVr: relative standardized uptake value. **** : P < 0.0001. AChA: anterior choroidal artery. MCA: middle cerebral artery. PCA: posterior cerebral artery.

Cognitive decline is accelerated in patients with small AChAs

Previous studies have shown that higher MTL tau levels in individuals with MCI is associated with accelerated cognitive decline.46,47 Given the observed relationship between AChA calibre and MTL tau, we tested whether smaller AChA diameters were also linked to accelerated cognitive decline. To do so, we analysed MRA images in 43 MCI individuals with at least two post-imaging cognitive assessments, allowing us to calculate the rate of cognitive decline, as defined by the yearly change in CDR-SB scores (CDR-SB pts/year) (see Methods). Participants with a CDR-SB pts./year value greater than zero were assumed to be in ‘fast’ cognitive decline (N = 23, +1.37 pts./year) while the remaining were assumed to be in ‘slow’ cognitive decline (N = 20, −0.45 pts./year). We found that participants with fast cognitive decline had significantly smaller AChA diameters at baseline compared to the stable group (P = 0.0039, Fig. 4A). No significant relationships were found between PCA (r = −0.18, P = 0.23) or MCA diameters (r = −0.05, P = 0.77, Fig. 4B). The correlation between baseline AChA diameter and rate of cognitive decline remained significant after adjusting for education and neocortical Aβ levels (without correcting for confounders: r = −0.40 P = 0.012; with correction of confounders: r = −0.35, P = 0.04, Fig. 4C). As in the previous analysis, no significant correlation was found between artery length and cognitive decline (all P > 0.09).

Figure 4.

This figure shows the association between the diameter of the anterior choroidal artery and the rate of cognitive decline, such that those with faster rate of cognitive decline have smaller anterior choroidal arteries.

AChA diameter is associated with the rate of cognitive decline. (A) Average AChA diameters are smaller in declining MCI subjects (N = 23 participants) versus stable MCI (N = 20 participants). Student’s t-test was used to compare both groups (t = 3.059, P = 0.0039). (B) The correlation between baseline artery diameter and decline rate was significant only for the AChA, not for other CW arteries. (C) Same data as in (A), but viewed as a scatter plot with correlation adjusted for education and amyloid. Spearman’s rank correlation was used to assess these relationships. In sub-panel A and C, each datapoint represents a participant. AChA: anterior choroidal artery. MCA: middle cerebral artery. PCA: posterior cerebral artery. CDR-SB pts: clinical dementia rating—sum of boxes points.

Discussion

A remarkable feature of tau deposition is its predictable anatomical progression through the brain. Tau deposits typically first appear in the MTL, then spread in an orderly sequence to limbic, association and finally sensory cortices.14,48,49 While several studies have investigated the mechanisms facilitating the spread of tau from the MTL to other brain regions,50-52 the reason the MTL is particularly vulnerable to the initial insult remains unclear. Selective vulnerability in neurodegenerative diseases describes the phenomenon whereby specific brain regions or cell types succumb to degeneration earlier and more severely than others. Two theories have been proposed to explain this phenomenon: the neuronal theory, which emphasizes intrinsic neuronal properties, and the vascular theory, which focuses on blood supply and neurovascular interactions.53 The vascular theory originated in early 20th century studies of stroke and ischaemia, which highlighted how regions with inherently poor blood supply are the first to succumb to hypoxia and oxidative stress.26,54 In contrast, the neuronal theory gained prominence later, driven by advances in molecular biology. It emphasizes intrinsic factors like metabolic stress,55 neuroplasticity burden56 and gene expression57 that render certain neurons particularly vulnerable. Since then, the neuronal theory has become the dominant explanation for selective vulnerability in AD.15,58 In this context, the present study brings renewed attention to a vascular-based model of selective vulnerability. We observed that individuals with narrower AChAs exhibited higher MTL tau levels and accelerated cognitive decline. A reduced arterial calibre may reflect a limited perfusion reserve, potentially rendering the MTL tissue more susceptible to metabolic stress and impaired protein clearance, thereby creating an environment that promotes tau formation,59 neurodegeneration24,25 and ultimately, cognitive decline.

This interpretation is supported by multiple experimental studies showing that ischaemia induces marked increases in pathological tau protein,60-62 which is presumably a pathological response to hypoxia-related mechanisms.20-23 According to our ss-ASL data and previous post-mortem studies,33 the anterior portion of the MTL, which is the initial site of tau accumulation,63 is primarily supplied by the AChA. Consistently, correlations between AChA diameter and tau burden were strongest in the amygdala, a region heavily relying on the AChA for blood supply. Overall, these results indicate that inefficient vascular supply may represent an amyloid-independent regulator of the topographical selectivity of early tau protein accumulation.11,64

Nonetheless, the precise cause of a narrow AChA is unclear. Post hoc analysis revealed a lack of correlation between artery diameter and the number of cardiovascular risk factors, the latter of which are strongly linked to atherosclerotic lesions. In addition, the link between AChA diameter and amyloid burden was very weak. Collectively, these observations imply that AChA calibre may be an inherent interindividual vascular trait marking reduced resilience, rather than a direct consequence of atherosclerotic or amyloid angiopathy-related changes. These variations in AChA calibre may represent a developmentally determined vascular set point, established during early arterial competition, that influences lifelong regional resilience to neurodegenerative processes.

A key strength of this study is that it highlights MRA and vascular morphology analysis30,65,66 as important tools for better understanding neurodegenerative disorders. The results from this study, combined with recent advances in non-contrast-enhanced MRA image analysis, underscore the importance of including blood vessel structure in neuroimaging studies. However, certain limitations should be acknowledged. Although our results suggest that vascular factors may underlie selective vulnerability, the directionality of the association between AChA diameter and tau burden remains uncertain. It is possible that tau accumulation leads to loss of function in neurons and reduced firing rates, resulting in lower metabolic demand and, consequently, reduced blood flow through neurovascular coupling. If that is the case, AChA diameter changes would be secondary to tau deposition. Longitudinal studies are therefore needed to assess the temporal sequence between arterial narrowing and tau deposition. Additionally, the lack of available Alzheimer’s disease biomarkers other than PET imaging (i.e. fluid biomarkers) in this dataset limits our ability to further investigate the relationship between blood vessels and tau levels. Future studies using ss-ASL in elderly individuals would also be required to confirm the hypothesis that reduced AChA calibre causes perfusion deficits in the anterior MTL. Finally, the relatively small size of our ss-ASL cohort and MCI cohort reduces statistical power, especially when controlling for multiple confounding variables. Future studies with larger cohorts will be necessary to confirm these findings and further investigate the vascular contribution to early tau pathology.

In a well-characterized population, we found that individuals with narrower AChA had increased tau levels and experienced faster cognitive decline. These results raise the possibility that the selective vulnerability of the MTL in aging and Alzheimer’s disease emerges, at least in part, from Aβ-independent vascular dysfunction.

Acknowledgements

Data were provided by OASIS-3: Longitudinal Multimodal Neuroimaging: Principal Investigators: T. Benzinger, D. Marcus, J. Morris; NIH P50 AG00561, P30 NS09857781, P01 AG026276, P01 AG003991, R01 AG043434, UL1 TR000448 and R01 EB009352. Some icons in the graphical abstract were designed by Magnific.

Contributor Information

Vincent Doyon, Department of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Félix Janelle, Department of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada; Department of Surgery, Université de Montréal, Montréal H3T 1J4, Canada.

Monica Sean, Department of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Davy Vanderweyen, Department of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Samantha Côté, Department of Psychology, Bishop’s University, Sherbrooke J1M 1Z7, Canada.

Julia Huck, Department of Radiology, University of Calgary, Calgary T2N 1N4, Canada.

Pascal Tétreault, Department of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada; Department of Anesthesiology, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Jean-François Lepage, Department of Pediatrics, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Jose Gutierrez, Department of Neurology, University of Miami Miller School of Medicine, Miami 33136, USA.

Christian Bocti, Department of Medicine, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Tamàs Fülöp, Department of Medicine, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Alexa Pichet-Binette, Department of Pharmacology and Physiology, Université de Montréal, Montréal H3T 1J4, Canada; Centre de Recherche de L’Institut Universitaire de Gériatrie de Montréal, Montréal H3W 1W6, Canada.

Kevin Whittingstall, Department of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke J1H 5N4, Canada; Department of Diagnostic Radiology, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Funding

K.W. holds a research chair in Cerebrovascular Imaging and is supported by the Natural Sciences and Engineering Council of Canada (NSERC, grant number RPGIN-2024-06118) and the J.-Louis Lévesque Foundation.

Competing interests

The authors report no competing interests.

Data availability

eICAB, the artery segmentation and measurement algorithm, is available at the following repository: https://gitlab.com/FelixDumais/vessel_segmentation_snaillab. The OASIS dataset is available upon request. More information at: https://sites.wustl.edu/oasisbrains/request-access/.

References

  • 1. Eichenbaum  H, Yonelinas  AP, Ranganath  C. The medial temporal lobe and recognition memory. Annu Rev Neurosci. 2007;30:123–152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Squire  LR, Stark  CEL, Clark  RE. The medial temporal lobe. Annu Rev Neurosci. 2004;27:279–306. [DOI] [PubMed] [Google Scholar]
  • 3. Coupé  P, Manjón  JV, Lanuza  E, Catheline  G. Lifespan changes of the human brain in Alzheimer’s disease. Sci Rep. 2019;9(1):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lowe  VJ, Wiste  HJ, Senjem  ML, et al.  Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia. Brain. 2018;141(1):271–287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Wang  JZ, Liu  F. Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol. 2008;85(2):148–175. [DOI] [PubMed] [Google Scholar]
  • 6. Ossenkoppele  R, Pichet Binette  A, Groot  C, et al.  Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28(11):2381–2387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Groot  C, Smith  R, Collij  LE, et al.  Tau positron emission tomography for predicting dementia in individuals with mild cognitive impairment. JAMA Neurol. 2024;81(8):845–856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Kwan  ATH, Arfaie  S, Therriault  J, et al.  Medial temporal tau predicts memory decline in cognitively unimpaired elderly. Brain Commun. 2022;5(1):fcac325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Ozlen  H, Pichet Binette  A, Köbe  T, et al.  Spatial extent of amyloid-β levels and associations with Tau-PET and cognition. JAMA Neurol. 2022;79(10):1025–1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Cai  Y, Du  J, Li  A, et al.  Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease. Alzheimers Res Ther. 2023;15(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Aksman  LM, Oxtoby  NP, Scelsi  MA, et al.  A data-driven study of Alzheimer’s disease related amyloid and tau pathology progression. Brain. 2023;146(12):4935–4948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Braak  H, Thal  DR, Ghebremedhin  E, Del Tredici  K. Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960–969. [DOI] [PubMed] [Google Scholar]
  • 13. Braak  H, Zetterberg  H, Del Tredici  K, Blennow  K. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid. Acta Neuropathol. 2013;126(5):631–641. [DOI] [PubMed] [Google Scholar]
  • 14. van der Kant  R, Goldstein  LSB, Ossenkoppele  R. Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020;21(1):21–35. [DOI] [PubMed] [Google Scholar]
  • 15. Fu  H, Hardy  J, Duff  KE. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1350–1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Roher  AE, Esh  C, Kokjohn  TA, et al.  Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer’s disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2055–2062. [DOI] [PubMed] [Google Scholar]
  • 17. Beach  TG, Wilson  JR, Sue  LI, et al.  Circle of willis atherosclerosis: Association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. 2007;113(1):13–21. [DOI] [PubMed] [Google Scholar]
  • 18. Roher  AE, Tyas  SL, Maarouf  CL, et al.  Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimer’s and Dementia. 2011;7(4):436–444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Yarchoan  M, Xie  SX, Kling  MA, et al.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012;135(12):3749–3756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Raz  L, Bhaskar  K, Weaver  J, et al.  Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction. Neurobiol Dis. 2019;126:124–136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Park  J, Jung  S, Kim  SM, et al.  Repeated hypoxia exposure induces cognitive dysfunction, brain inflammation, and amyloidβ/p-Tau accumulation through reduced brain O-GlcNAcylation in zebrafish. J Cereb Blood Flow Metab. 2021;41(11):3111–3126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kazim  SF, Sharma  A, Saroja  SR, et al.  Chronic intermittent hypoxia enhances pathological Tau seeding, propagation, and accumulation and exacerbates Alzheimer-like memory and synaptic plasticity deficits and molecular signatures. Biol Psychiatry. 2022;91(4):346–358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Qiu  L, Ng  G, Tan  EK, Liao  P, Kandiah  N, Zeng  L. Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice. Sci Rep. 2016;6:23964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Perosa  V, Priester  A, Ziegler  G, et al.  Hippocampal vascular reserve associated with cognitive performance and hippocampal volume. Brain. 2020;143(2):622–634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Vockert  N, Perosa  V, Ziegler  G, et al.  Hippocampal vascularization patterns exert local and distant effects on brain structure but not vascular pathology in old age. Brain Commun. 2021;3(3):fcab127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Scharrer  E. VASCULARIZATION AND VULNERABILITY OF THE CORNU AMMONIS IN THE OPOSSUM. Arch Neurol Psychiatry. 1940;44(3):483–506. [Google Scholar]
  • 27. Murazaki  H, Wada  T, Togao  O, et al.  Optimization of 4D-MR angiography based on superselective pseudo-continuous arterial spin labeling combined with CENTRA-keyhole and view-sharing (4D-S-PACK) for vessel-selective visualization of the internal carotid artery and vertebrobasilar artery systems. Magn Reson Imaging. 2022;85:287–296. [DOI] [PubMed] [Google Scholar]
  • 28. Henschel  L, Conjeti  S, Estrada  S, Diers  K, Fischl  B, Reuter  M. FastSurfer—A fast and accurate deep learning based neuroimaging pipeline. Neuroimage. 2020;219:117012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Koenig  LN, Day  GS, Salter  A, et al.  Select atrophied regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia. Neuroimage Clin. 2020;26:102248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Dumais  F, Caceres  MP, Janelle  F, et al.  eICAB: A novel deep learning pipeline for circle of willis multiclass segmentation and analysis. Neuroimage. 2022;260:119425. [DOI] [PubMed] [Google Scholar]
  • 31. Huck  J, Vanderweyen  D, Rundek  T, et al.  Accurate and fully automated diameter measurements of circle of willis arteries on MRA imaging. J Cereb Blood Flow Metab. 2025;45(9):1774–1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Johnson  AC. Hippocampal vascular supply and its role in vascular cognitive impairment. Stroke. 2023;54(3):673–685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Huther  G, Dörfl  J, Van der Loos  H, Jeanmonod  D. Microanatomic and vascular aspects of the temporomesial region. Neurosurgery. 1998;43(5):1118–1136. [DOI] [PubMed] [Google Scholar]
  • 34. Wen  HT, Rhoton  AL, De Oliveira  E, et al.  Microsurgical anatomy of the temporal lobe: Part 1: Mesial temporal lobe anatomy and its vascular relationships as applied to amygdalohippocampectomy. Neurosurgery. 1999;45(3):549–592. [DOI] [PubMed] [Google Scholar]
  • 35. Gould  A, Chen  Z, Geleri  DB, et al.  Vessel length on SNAP MRA and TOF MRA is a potential imaging biomarker for brain blood flow. Magn Reson Imaging. 2021;79:20–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Lee  CM, Jacobs  HIL, Marquié  M, et al.  18F-Flortaucipir binding in choroid Plexus: Related to race and hippocampus signal. J Alzheimers Dis. 2018;62(4):1691–1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. LaMontagne  PJ, Benzinger  TLS, Morris  JC, et al.  OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease. medRxiv. [Preprint]. doi: 10.1101/2019.12.13.19014902 [DOI]
  • 38. O’Bryant  SE, Waring  SC, Cullum  CM, et al.  Staging dementia using clinical dementia rating scale sum of boxes scores: A Texas Alzheimer’s research consortium study. Arch Neurol. 2008;65(8):1091–1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Daly  E, Zaitchik  D, Copeland  M, Schmahmann  J, Gunther  J, Albert  MS. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol. 2000;57(5):675–680. [DOI] [PubMed] [Google Scholar]
  • 40. Kim  BS, Jun  S, Kim  H. Cognitive trajectories and associated biomarkers in patients with mild cognitive impairment. J Alzheimers Dis. 2023;92(3):803–814. [DOI] [PubMed] [Google Scholar]
  • 41. Kim  YJ, Cho  SK, Kim  HJ, et al.  Data-driven prognostic features of cognitive trajectories in patients with amnestic mild cognitive impairments. Alzheimers Res Ther. 2019;11(1):10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Gutierrez  J, Honig  L, Elkind  MSV, et al.  Brain arterial aging and its relationship to Alzheimer dementia. Neurology. 2016;86(16):1507–1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Baker  JE, Lim  YY, Pietrzak  RH, et al.  Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimers Dement (Amst). 2016;6:108–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Ye  BS, Seo  SW, Cho  H, et al.  Effects of education on the progression of early- versus late-stage mild cognitive impairment. Int Psychogeriatr. 2013;25(4):597–606. [DOI] [PubMed] [Google Scholar]
  • 45. Fernández-Miranda  JC, De Oliveira  E, Rubino  PA, Wen  HT, Rhoton  AL. Microvascular anatomy of the medial temporal region: Part 1: Its application to arteriovenous malformation surgery. Neurosurgery. 2010;67(SUPPL. 1):ons237–ons276. [DOI] [PubMed] [Google Scholar]
  • 46. Costoya-Sánchez  A, Moscoso  A, Silva-Rodríguez  J, et al.  Increased medial temporal Tau positron emission tomography uptake in the absence of amyloid-β positivity. JAMA Neurol. 2023;80(10):1051–1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Berron  D, Vogel  JW, Insel  PS, et al.  Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Brain. 2021;144(9):2771–2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Braak  H, Braak  E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. [DOI] [PubMed] [Google Scholar]
  • 49. Braak  H, Braak  E. Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol Scand Suppl. 1996;165(SUPPL.165):3–12. [DOI] [PubMed] [Google Scholar]
  • 50. Sepulcre  J, Grothe  MJ, d’Oleire Uquillas  F, et al.  Neurogenetic contributions to amyloid beta and tau spreading in the human cortex. Nat Med. 2018;24(12):1910–1918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Montal  V, Diez  I, Kim  CM, et al.  Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Sci Transl Med. 2022;14(655):eabn7273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Vogel  JW, Corriveau-Lecavalier  N, Franzmeier  N, et al.  Connectome-based modelling of neurodegenerative diseases: Towards precision medicine and mechanistic insight. Nat Rev Neurosci. 2023;24:1–20. [DOI] [PubMed] [Google Scholar]
  • 53. Schmidt-Kastner  R. Genomic approach to selective vulnerability of the hippocampus in brain ischemia–hypoxia. Neuroscience. 2015;309:259–279. [DOI] [PubMed] [Google Scholar]
  • 54. Spielmeyer  W. THE ANATOMIC SUBSTRATUM OF THE CONVULSIVE STATE. Arch Neurol Psychiatry. 1930;23(5):869–875. [Google Scholar]
  • 55. Muddapu  VR, Dharshini  SAP, Chakravarthy  VS, Gromiha  MM. Neurodegenerative diseases—Is metabolic deficiency the root cause?  Front Neurosci. 2020;14:213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Mesulam  MM. Neuroplasticity failure in Alzheimer’s disease: Bridging the gap between plaques and tangles. Neuron. 1999;24(3):521–529. [DOI] [PubMed] [Google Scholar]
  • 57. Roussarie  JP, Yao  V, Rodriguez-Rodriguez  P, et al.  Selective neuronal vulnerability in Alzheimer’s disease: A network-based analysis. Neuron. 2020;107(5):821-835.e12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Saxena  S, Caroni  P. Selective neuronal vulnerability in neurodegenerative diseases: From stressor thresholds to degeneration. Neuron. 2011;71(1):35–48. [DOI] [PubMed] [Google Scholar]
  • 59. Kelleher  RJ, Soiza  RL. Evidence of endothelial dysfunction in the development of Alzheimer’s disease: Is Alzheimer’s a vascular disorder?  Am J Cardiovasc Dis. 2013;3(4):197–226. [PMC free article] [PubMed] [Google Scholar]
  • 60. Pluta  R, Czuczwar  SJ, Januszewski  S, Jabłoński  M. The many faces of post-ischemic Tau protein in brain neurodegeneration of the Alzheimer’s disease type. Cells. 2021;10(9):2213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Korte  N, Nortley  R, Attwell  D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer’s disease. Acta Neuropathol. 2020;140(6):793–810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. de la Torre  JC. Deciphering Alzheimer’s disease pathogenic pathway: Role of chronic brain hypoperfusion on p-Tau and mTOR. J Alzheimers Dis. 2021;79(4):1381–1396. [DOI] [PubMed] [Google Scholar]
  • 63. Ravikumar  S, Denning  AE, Lim  S, et al.  Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer’s disease. Nat Commun. 2024;15(1):4803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Wuestefeld  A, Pichet Binette  A, Berron  D, et al.  Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023;146(8):3192–3205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Bernier  M, Cunnane  SC, Whittingstall  K. The morphology of the human cerebrovascular system. Hum Brain Mapp. 2018;39(July):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Bizeau  A, Gilbert  G, Bernier  M, et al.  Stimulus-evoked changes in cerebral vessel diameter: A study in healthy humans. J Cereb Blood Flow Metab. 2018;38(3):528–539. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Citations

  1. LaMontagne  PJ, Benzinger  TLS, Morris  JC, et al.  OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease. medRxiv. [Preprint]. doi: 10.1101/2019.12.13.19014902 [DOI]

Data Availability Statement

eICAB, the artery segmentation and measurement algorithm, is available at the following repository: https://gitlab.com/FelixDumais/vessel_segmentation_snaillab. The OASIS dataset is available upon request. More information at: https://sites.wustl.edu/oasisbrains/request-access/.


Articles from Brain Communications are provided here courtesy of Oxford University Press

RESOURCES